Hydrochlorothiazide (HCTZ)
Thiazide diuretic for high blood pressure and edema
Quick facts about Hydrochlorothiazide
Key takeaways about Hydrochlorothiazide
- First-line treatment for hypertension: Hydrochlorothiazide is one of the most widely prescribed blood pressure medications worldwide, recommended by major guidelines as a first-line option
- Monitor electrolytes regularly: HCTZ can lower potassium and sodium levels in the blood, so regular blood tests are important during treatment
- Take in the morning: To avoid nighttime urination, take your dose in the morning. The diuretic effect starts within 2 hours and lasts approximately 6-12 hours
- Sun protection is important: Long-term use may increase the risk of non-melanoma skin cancer. Protect your skin from sun exposure while taking this medication
- Not recommended in pregnancy: Hydrochlorothiazide can harm the fetus, especially during the last 6 months of pregnancy. Discuss alternatives with your doctor
What Is Hydrochlorothiazide and What Is It Used For?
Hydrochlorothiazide (HCTZ) is a thiazide diuretic that lowers blood pressure by increasing urine production and reducing blood volume. It also dilates certain blood vessels (arterioles), decreasing peripheral vascular resistance. HCTZ is primarily prescribed for hypertension and edema.
Hydrochlorothiazide belongs to a class of medications called thiazide diuretics, sometimes known as "water pills." These medications work primarily in the kidneys, specifically in the distal convoluted tubule, where they block the reabsorption of sodium and chloride ions. This causes the kidneys to excrete more water and electrolytes in the urine, which reduces the total volume of fluid in the body and lowers blood pressure.
The blood pressure lowering effect of hydrochlorothiazide is twofold. In the short term, it reduces blood volume through increased urine output. In the longer term, it also appears to cause relaxation of the smooth muscle in arteriolar walls, which decreases peripheral vascular resistance. This combined mechanism makes HCTZ a particularly effective antihypertensive agent.
Hydrochlorothiazide is one of the most commonly prescribed medications in the world. It has been available since the late 1950s and has decades of clinical evidence supporting its efficacy and safety. Major international guidelines, including those from the European Society of Cardiology (ESC), the American Heart Association (AHA), and the World Health Organization (WHO), recommend thiazide diuretics as a first-line treatment option for hypertension.
Primary indications
Hydrochlorothiazide is approved for two main conditions:
- High blood pressure (hypertension): HCTZ is used either alone or in combination with other antihypertensive medications to lower blood pressure. Effective blood pressure control reduces the risk of stroke, heart attack, kidney disease, and heart failure.
- Fluid retention (edema): HCTZ helps the body eliminate excess fluid that may accumulate in conditions such as heart failure, liver disease, kidney disorders, or as a side effect of certain medications such as corticosteroids.
Hydrochlorothiazide is often combined with other blood pressure medications such as ACE inhibitors (e.g. enalapril, ramipril), angiotensin receptor blockers (e.g. losartan, candesartan), or beta-blockers (e.g. bisoprolol) in a single tablet for convenience and improved blood pressure control.
What Should You Know Before Taking Hydrochlorothiazide?
Do not take hydrochlorothiazide if you are allergic to it, other thiazide diuretics, or sulfonamide antibiotics. It is contraindicated in severe liver or kidney disease and gout. Tell your doctor about all other medications you take, especially lithium, NSAIDs, digoxin, and diabetes medications.
Before starting hydrochlorothiazide, it is important to inform your healthcare provider about your full medical history, all medications you are currently taking (including over-the-counter drugs and supplements), and any allergies you may have. Several conditions and situations require special caution or may prevent you from taking this medication safely.
Contraindications
You should not take hydrochlorothiazide if:
- You are allergic to hydrochlorothiazide or any of the inactive ingredients in the tablet (including lactose monohydrate, maize starch, talc, colloidal anhydrous silica, and magnesium stearate)
- You are allergic to other thiazide diuretics
- You are allergic to sulfonamide antibiotics (a potential cross-sensitivity exists)
- You have severe liver disease or hepatic encephalopathy
- You have severe kidney disease (anuria or severe renal impairment)
- You have gout or significantly elevated uric acid levels
Warnings and Precautions
Talk to your doctor before taking hydrochlorothiazide if you have any of the following conditions, as your treatment may need to be adjusted or you may require closer monitoring:
- Diabetes: HCTZ can raise blood sugar levels, which may require adjustment of your diabetes medication
- Atherosclerosis of the brain or heart vessels
- Low potassium levels (hypokalemia): Symptoms may include muscle weakness, cramps, and abnormal heart rhythm
- Low sodium levels (hyponatremia): Symptoms may include fatigue, confusion, muscle cramps, and seizures
- High calcium levels (hypercalcemia): Symptoms may include nausea, vomiting, constipation, and frequent urination
- High uric acid levels in the blood
- Asthma or allergic conditions
- History of skin cancer: Long-term use of HCTZ, particularly at high doses, may increase the risk of non-melanoma skin cancer (basal cell carcinoma and squamous cell carcinoma)
- Reduced vision or eye pain – may indicate fluid accumulation in the eye or acute angle-closure glaucoma
- Severe shortness of breath, fever, weakness, and confusion – may indicate acute respiratory distress syndrome (ARDS)
- Severe skin reactions such as peeling or blistering – may indicate toxic epidermal necrolysis
- Signs of infection with high fever and severely reduced general condition – may indicate agranulocytosis (severe reduction of white blood cells)
Pregnancy and Breastfeeding
Hydrochlorothiazide is not recommended during pregnancy, especially during the last six months. The medication crosses the placenta and may potentially harm the fetus and newborn, causing effects such as electrolyte imbalances, jaundice, and thrombocytopenia in the newborn. Your doctor will usually recommend a safer alternative blood pressure medication during pregnancy.
Hydrochlorothiazide is also not recommended during breastfeeding, as it passes into breast milk and may reduce milk production. If blood pressure treatment is needed while breastfeeding, your doctor can help you find a suitable alternative.
If you are pregnant, think you may be pregnant, or are planning to become pregnant, always consult your healthcare provider before taking any medication.
Driving and operating machinery
Hydrochlorothiazide generally has little or no effect on the ability to drive and use machines. However, some people may experience dizziness, especially at the beginning of treatment or when the dose is increased. If you experience dizziness or lightheadedness, avoid driving or operating machinery until you know how the medication affects you.
Lactose content
Hydrochlorothiazide tablets contain lactose monohydrate as an inactive ingredient. If you have been told by your doctor that you have an intolerance to certain sugars, contact your doctor before taking this medication.
How Does Hydrochlorothiazide Interact with Other Drugs?
Hydrochlorothiazide has clinically significant interactions with many common medications. Major interactions include lithium (increased toxicity risk), NSAIDs (reduced antihypertensive effect), digoxin (increased toxicity from hypokalemia), and diabetes medications (may need dose adjustment). Always inform your doctor about all medications you take.
Drug interactions can change how your medications work or increase your risk of serious side effects. Hydrochlorothiazide interacts with a wide range of medications because it affects electrolyte balance, blood pressure regulation, and kidney function. This section covers the most important interactions you should be aware of, but it is not exhaustive. Always tell your healthcare provider about all prescription and over-the-counter medications, vitamins, and herbal supplements you are taking.
Major Interactions
The following interactions may have significant clinical consequences and require careful monitoring or dose adjustment:
| Medication | Interaction | Clinical Significance |
|---|---|---|
| Lithium | HCTZ reduces lithium excretion by the kidneys | Increased risk of lithium toxicity. Serum lithium levels must be monitored closely. |
| Digoxin and cardiac glycosides | HCTZ-induced hypokalemia increases sensitivity to digitalis | Increased risk of dangerous cardiac arrhythmias. Potassium levels must be monitored. |
| NSAIDs (e.g. ibuprofen, naproxen, diclofenac) | NSAIDs reduce the blood pressure lowering and diuretic effect of HCTZ | Blood pressure may not be adequately controlled. May also worsen kidney function. |
| Sotalol and other QT-prolonging drugs | HCTZ-induced electrolyte imbalances increase the risk of cardiac arrhythmias | Risk of potentially fatal torsades de pointes. Regular ECG and electrolyte monitoring required. |
| Insulin and oral antidiabetics | HCTZ may raise blood sugar levels | Diabetes medication doses may need to be increased. More frequent blood sugar monitoring recommended. |
| Corticosteroids | Both drugs cause potassium loss | Significantly increased risk of hypokalemia. Potassium supplementation may be needed. |
Other Notable Interactions
The following interactions are also clinically relevant and should be discussed with your healthcare provider:
- Cholestyramine and colestipol: These cholesterol-lowering medications can reduce the absorption of HCTZ. Take HCTZ at least 1 hour before or 4-6 hours after these medications.
- Antidepressants and antipsychotics: Some of these medications can enhance the blood pressure lowering effect of HCTZ, increasing the risk of dizziness and fainting upon standing (orthostatic hypotension).
- SSRIs (selective serotonin reuptake inhibitors): Both SSRIs and HCTZ can lower sodium levels, increasing the risk of hyponatremia, particularly in elderly patients.
- Carbamazepine: When used with HCTZ, there is an increased risk of dangerously low sodium levels (hyponatremia).
- Anticholinergic medications: May increase the absorption and effect of HCTZ by slowing gastrointestinal motility.
- Amphotericin B and penicillin G: May increase the risk of electrolyte imbalances when used with HCTZ.
- Muscle relaxants (used during surgery): HCTZ may enhance the effect of non-depolarizing muscle relaxants such as tubocurarine.
- Pressor amines (e.g. adrenaline, noradrenaline): HCTZ may reduce the effect of these medications.
- Alcohol and sedatives: May enhance the blood pressure lowering effect of HCTZ, increasing the risk of dizziness and fainting.
Hydrochlorothiazide can be taken with or without food. During treatment, it is important to ensure adequate potassium intake through your diet (e.g. bananas, oranges, potatoes, spinach) unless otherwise directed by your doctor. Avoid excessive alcohol consumption as it may enhance the blood pressure lowering effect and increase the risk of dizziness.
What Is the Correct Dosage of Hydrochlorothiazide?
For hypertension, the recommended starting dose is 12.5 mg to 25 mg once daily, which may be increased to a maximum of 50 mg daily. For edema, doses of 25 mg to 50 mg daily are typical, with severe cases requiring up to 75-100 mg daily. The tablet should be taken in the morning with a glass of water.
Always take hydrochlorothiazide exactly as your doctor has prescribed. The dosage depends on your specific condition, its severity, and your response to treatment. Do not change your dose or stop taking the medication without consulting your doctor, even if you feel well. Your doctor will typically start with a low dose and adjust it based on your blood pressure readings and response to treatment.
Adults
| Condition | Starting Dose | Usual Dose | Maximum Dose |
|---|---|---|---|
| Hypertension | 12.5 mg once daily | 12.5–25 mg once daily | 50 mg/day |
| Edema (mild to moderate) | 25 mg once daily | 25–50 mg once daily | 50 mg/day |
| Edema (severe) | 25 mg once daily | 50–75 mg once daily | 100 mg/day |
The recommended dose should be taken in the morning, either as a single dose or divided into two doses (morning and evening), depending on what your doctor considers best for you. The tablets should be swallowed whole with a glass of water.
The increased urine output begins approximately 2 hours after taking the tablet, is greatest at approximately 4 hours, and lasts approximately 6-12 hours. Taking the medication in the morning helps to avoid disruptive nighttime urination.
Elderly Patients
Elderly patients may be more sensitive to the effects of hydrochlorothiazide, particularly with regard to electrolyte imbalances and orthostatic hypotension (dizziness upon standing). Doctors typically start with a lower dose, such as 12.5 mg daily, and increase cautiously based on response and tolerability. More frequent monitoring of kidney function, electrolytes, and blood pressure is recommended in this population.
Children
Hydrochlorothiazide may be prescribed for children with hypertension or edema under the supervision of a specialist. The dose is individualized based on the child's weight and clinical response. Pediatric dosing should always be determined and monitored by a pediatric cardiologist or nephrologist.
Missed Dose
If you forget to take your hydrochlorothiazide dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Never take a double dose to make up for a forgotten tablet.
Overdose
If you have taken more hydrochlorothiazide than prescribed, or if a child has accidentally ingested the medication, seek medical attention immediately or contact your local poison control center.
Symptoms of overdose may include:
- Severe disturbances in fluid and electrolyte balance
- Excessive thirst and dehydration
- Low blood pressure and rapid heart rate
- Disturbances in the body's acid-base balance
- Muscle weakness and cramping
- Nausea and vomiting
What Are the Side Effects of Hydrochlorothiazide?
Common side effects include weakness, dizziness, headache, and electrolyte imbalances (low potassium, elevated uric acid). Less common effects include low blood pressure when standing, irregular heartbeat, nausea, and sun sensitivity. Rare but serious effects include severe skin reactions, blood disorders, and acute eye problems. Report any unexpected symptoms to your doctor.
Like all medications, hydrochlorothiazide can cause side effects, although not everyone will experience them. Most side effects are dose-dependent and are more common at higher doses. Many side effects can be managed through dose adjustment, dietary changes, or by adding supplementary medications. If you experience any of the following serious side effects, stop taking hydrochlorothiazide and seek medical attention immediately.
- Agranulocytosis: Fever with severely reduced general condition, sore throat, mouth ulcers, or difficulty urinating – may indicate severe white blood cell deficiency
- Toxic epidermal necrolysis: Severe skin blistering and peeling affecting skin and mucous membranes – potentially life-threatening if not treated immediately
- Acute eye problems: Reduced vision, eye pain, redness, or seeing halos around lights with nausea – may indicate acute angle-closure glaucoma or choroidal effusion
- Acute respiratory distress syndrome (ARDS): Severe shortness of breath, fever, weakness, and confusion
Common
May affect up to 1 in 10 people
- Weakness, dizziness, fatigue, headache
- Low potassium levels (hypokalemia)
- Elevated uric acid levels in blood (may trigger gout)
- Elevated blood sugar levels (especially at higher doses)
- Elevated blood lipid levels (at higher doses)
Uncommon
May affect up to 1 in 100 people
- Dizziness or fainting when standing up (orthostatic hypotension)
- Irregular heartbeat (arrhythmia)
- Loss of appetite, nausea, vomiting, abdominal cramps
- Diarrhea or constipation
- Skin rash, hives (urticaria), increased sun sensitivity
- Disturbances in electrolyte and acid-base balance
Rare
May affect up to 1 in 1,000 people
- Severe allergic reactions (hypersensitivity)
- Skin peeling and scaling
- Fever
- Impotence (erectile dysfunction)
- Anemia, leukopenia (low white blood cells), agranulocytosis, thrombocytopenia (low platelets)
- Tingling sensations, sleep disturbances
- Depression
- Inflammation of blood vessels (vasculitis)
- Pancreatitis, impaired liver function
- Respiratory symptoms
- Impaired kidney function
- Blurred vision
Very Rare and Other Reported Effects
May affect up to 1 in 10,000 people or frequency unknown
- Acute respiratory distress syndrome (ARDS)
- Kidney failure, decreased kidney function
- Anemia due to bone marrow depression
- Rashes, muscle cramps
- Acute glaucoma (sudden increase in eye pressure)
- Non-melanoma skin cancer of the skin and lips (with long-term use)
Studies have shown that long-term use of hydrochlorothiazide, particularly at higher doses, may be associated with an increased risk of non-melanoma skin cancer (basal cell carcinoma and squamous cell carcinoma). While this risk is relatively small, patients taking HCTZ should protect their skin from excessive sun exposure and UV radiation. Regularly check your skin for any new or changing moles or lesions and report them to your doctor. If you have a history of skin cancer, discuss this with your doctor before starting HCTZ.
How Should You Store Hydrochlorothiazide?
Store hydrochlorothiazide at room temperature in its original packaging to protect it from light. Keep out of reach of children. Do not use after the expiration date printed on the packaging. Never dispose of medications in wastewater or household waste.
Proper storage of hydrochlorothiazide is important to maintain its effectiveness and safety. Follow these storage guidelines:
- Keep out of sight and reach of children at all times
- Do not use after the expiration date printed on the carton and blister pack after "EXP." The expiration date refers to the last day of the stated month.
- No special temperature storage requirements. Store at room temperature.
- Store in the original packaging to protect from light, as hydrochlorothiazide is light-sensitive.
- Do not dispose of medications in wastewater or household waste. Return unused or expired medications to your pharmacy for proper disposal. These measures help protect the environment.
What Does Hydrochlorothiazide Contain?
Each tablet contains hydrochlorothiazide as the active ingredient (12.5 mg or 25 mg). Inactive ingredients include lactose monohydrate, maize starch, talc, colloidal anhydrous silica, and magnesium stearate. The tablets are white and round.
Active ingredient
The active substance is hydrochlorothiazide:
- 12.5 mg tablets: Each tablet contains 12.5 mg hydrochlorothiazide. White, round, biconvex tablets.
- 25 mg tablets: Each tablet contains 25 mg hydrochlorothiazide. White, round, flat tablets with a score line on one side (allowing the tablet to be divided into two equal doses).
Inactive ingredients (excipients)
The other ingredients are:
- Lactose monohydrate
- Maize starch
- Talc
- Colloidal anhydrous silica (silicon dioxide)
- Magnesium stearate
Packaging
Hydrochlorothiazide is available in PVC/aluminium blister packs:
- 12.5 mg: Packs of 100 and 250 tablets
- 25 mg: Packs of 100 tablets
Not all pack sizes may be marketed in all countries.
Frequently Asked Questions About Hydrochlorothiazide
Medical References and Sources
This article is based on current medical research and international guidelines. All claims are supported by scientific evidence from peer-reviewed sources.
- European Society of Cardiology / European Society of Hypertension (ESC/ESH) (2023). "Guidelines for the Management of Arterial Hypertension." European Heart Journal. International guidelines recommending thiazide diuretics as first-line antihypertensive therapy. Evidence level: 1A.
- ALLHAT Officers and Coordinators (2002). "Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic." JAMA. 288(23):2981-97. doi:10.1001/jama.288.23.2981 Landmark trial demonstrating thiazide diuretics as effective first-line therapy for hypertension.
- World Health Organization (WHO) (2023). "Model List of Essential Medicines – 23rd List." WHO Essential Medicines Hydrochlorothiazide is listed as an essential medicine for cardiovascular disorders.
- European Medicines Agency (EMA) (2018). "Review of hydrochlorothiazide-containing medicines – Skin cancer risk." EMA EMA safety review on the risk of non-melanoma skin cancer with long-term HCTZ use.
- Whelton PK, et al. (2018). "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults." Journal of the American College of Cardiology. 71(19):e127-e248. Comprehensive U.S. guidelines for hypertension management including thiazide diuretics.
- National Institute for Health and Care Excellence (NICE) (2022). "Hypertension in adults: diagnosis and management. NICE guideline [NG136]." NICE Guidelines UK clinical guidelines for hypertension management, including role of thiazide-like diuretics.
- British National Formulary (BNF) (2025). "Hydrochlorothiazide: Indications, dose, contraindications, side-effects, interactions." Comprehensive UK drug reference used by healthcare professionals.
Evidence grading: This article uses the GRADE framework (Grading of Recommendations Assessment, Development and Evaluation) for evidence-based medicine. Evidence level 1A represents the highest quality of evidence, based on systematic reviews of randomized controlled trials.
iMedic Editorial Standards
Peer Review Process
All medical content is reviewed by at least two licensed specialist physicians before publication.
Fact-Checking
All medical claims are verified against peer-reviewed sources and international guidelines.
Update Frequency
Content is reviewed and updated at least every 12 months or when new research emerges.
Corrections Policy
Any errors are corrected immediately with transparent changelog.
Medical Editorial Board: iMedic has an independent medical editorial board consisting of specialist physicians in pharmacology, cardiology, internal medicine, and nephrology.